Topic Editors

Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

Signaling Pathways in Liver Disease 2nd Edition

Abstract submission deadline
20 January 2026
Manuscript submission deadline
20 March 2026
Viewed by
197

Topic Information

Dear Colleagues,

Liver diseases, both acute and chronic, represent intricate disorders influenced by a multitude of pathogenic signaling pathways. These pathways play a crucial role in regulating the functions of both parenchymal and non-parenchymal liver cells. Central to these processes are networks of cytokines and chemokines that coordinate an inflammatory response, which in turn facilitates the recruitment and activation of various subsets of leukocytes. Additionally, specific molecular mediators engage distinct signaling pathways that contribute to the increased production of extracellular matrix components. Concurrently, different classes of reactive species are generated, leading to heightened oxidative and nitrosative stress, ultimately resulting in damage to liver cells. The ongoing cycle of liver injury can progress from inflammation to more severe conditions, such as fibrosis, cirrhosis, and hepatocellular carcinoma. Currently, extensive research efforts, both basic and clinical, are being conducted to explore these fundamental molecular mechanisms at even the single-cell level. We invite you to share your insights through original research articles, comprehensive reviews, or concise perspective pieces focused on the overarching theme of “Signaling Pathways in Liver Disease 2nd Edition”. Contributions that delve into mechanistic details, functional implications, cellular interactions, biochemical processes, diagnostics, therapy, or general considerations related to acute and chronic liver conditions are particularly encouraged. We look forward to your valuable contributions!

Prof. Dr. Ralf Weiskirchen
Dr. Amedeo Amedei
Topic Editors

Keywords

  • fibrosis
  • cirrhosis
  • hepatocellular carcinoma
  • metabolic dysfunction-associated steatohepatitis (MASH)
  • metabolic dysfunction-associated steatotic liver disease (MASLD)
  • extracellular matrix
  • signal transduction pathways
  • therapeutic targets
  • diagnostic tools
  • therapy 

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Biomolecules
biomolecules
4.8 9.4 2011 18.4 Days CHF 2700 Submit
Cancers
cancers
4.5 8.0 2009 17.4 Days CHF 2900 Submit
Cells
cells
5.1 9.9 2012 17 Days CHF 2700 Submit
Journal of Molecular Pathology
jmp
- - 2020 26.5 Days CHF 1000 Submit
Livers
livers
- 2.0 2021 27.2 Days CHF 1000 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers

This Topic is now open for submission.
Back to TopTop